MindRank Completes $7 Million Angel Round for AI Drug Development
June 23, 2021 at 06:04 AM EDT
Hangzhou MindRank AI completed a $7 million angel found from Sherpa Medical Fund to develop its AI-based drug development technology. In 2018, MindRank was formed in London , where several prominent AI-drug development companies are located. In late 2020, MindRank moved to Hangzhou to bring its one-stop AI drug research and development technology to China . It plans to ramp up its commercialization cooperation and pipeline development as quickly as possible. Proceeds from this round will be used for team building, business expansion and pipeline development. More details.... Share this with colleagues: // //
